Postmortem studies of Parkinson’s disease (PD) brain have consistently reported deficits of nigrostriatal glutathione (GSH) – the most abundant antioxidant in living tissue – of up to 40% compared to normal brain, strongly implicating oxidative stress in the pathophysiology of PD. However, direct evidence corroborating a striatal GSH deficit in PD brain in vivo is currently lacking. Using J-edited 1H MRS, this study measured striatal GSH in vivo in patients with PD and in matched control subjects, and found not only a 15% deficit of striatal GSH in PD that corroborated postmortem data, but also evidence of nigrostriatal neurodegeneration in the disorder.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords